Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 6 of 73 · 7,256 total
CLIK: 20-F · periodic report
CLIK · 20-F · 2026-10-22
TR: 8-K · earnings release
TR · 8-K · 2026-10-22
MSGY: 6-K · acquisition merger
MSGY · 6-K · 2026-10-22
XXII: 8-K · earnings release
XXII · 8-K · 2026-10-22
AXREF: 6-K · foreign private issuer
AXREF · 6-K · 2026-10-22
JUVF: 8-K · earnings release
JUVF · 8-K · 2026-10-22
GCBC: 8-K · earnings release
GCBC · 8-K · 2026-10-22
HON: 10-Q · periodic report
HON · 10-Q · 2026-10-22
WKEY: 6-K · other
WKEY · 6-K · 2026-10-22
MAYS: 8-K · earnings release
MAYS · 8-K · 2026-10-22
AIRE: S-1 · offering registration
AIRE · S-1 · 2026-10-22
MAYS: 10-K · periodic report
MAYS · 10-K · 2026-10-22
POOL: 8-K · earnings release
POOL · 8-K · 2026-10-22
MOH: 10-Q · periodic report
MOH · 10-Q · 2026-10-22
ALLT: 6-K · proxy statement
ALLT · 6-K · 2026-10-22
EBAY: 8-K · other
EBAY · 8-K · 2026-10-22
PLBC: 8-K · leadership change
PLBC · 8-K · 2026-10-22
WLDS: 6-K · material agreement
WLDS · 6-K · 2026-10-22
TLK: 6-K · share repurchase
TLK · 6-K · 2026-10-22
AEHL: 424B5 · prospectus supplement
AEHL · 424B5 · 2026-10-22
FMFG: 8-K · earnings release
FMFG · 8-K · 2026-10-22
BDCO: 8-K · leadership change
BDCO · 8-K · 2026-10-22
ORKT: 6-K · earnings release
ORKT · 6-K · 2026-10-22
CLMB: 8-K · acquisition merger
CLMB · 8-K · 2026-10-22
LND: 6-K · acquisition merger
LND · 6-K · 2026-10-22
EPRX: 6-K · other
EPRX · 6-K · 2026-10-22
ORI: 8-K · earnings release
ORI · 8-K · 2026-10-22
BLDP: 6-K · other
BLDP · 6-K · 2026-10-22
KRNY: 8-K · earnings release
KRNY · 8-K · 2026-10-22
BMI: 8-K · earnings release
BMI · 8-K · 2026-10-22
TCBI: 10-Q · periodic report
TCBI · 10-Q · 2026-10-22
DRTS: 6-K · clinical trial
DRTS · 6-K · 2026-10-22
CXAI: 8-K · material agreement
CXAI · 8-K · 2026-10-22
NTWO: 8-K · material agreement
NTWO · 8-K · 2026-10-22
ECBK: 8-K · earnings release
ECBK · 8-K · 2026-10-22
ARGX: 6-K · earnings release
ARGX · 6-K · 2026-10-22
CASS: 8-K · earnings release
CASS · 8-K · 2026-10-22
VLO: 8-K · earnings release
VLO · 8-K · 2026-10-22
NSC: 8-K · earnings release
NSC · 8-K · 2026-10-22
AUNA: 6-K · other
AUNA · 6-K · 2026-10-22
MBX: 8-K · leadership change
MBX · 8-K · 2026-10-22
AESI: 8-K · debt financing
AESI · 8-K · 2026-10-22
ACNB: 8-K · earnings release
ACNB · 8-K · 2026-10-22
TWG: 6-K · reverse split
TWG · 6-K · 2026-10-22
NBIS: 6-K · debt financing
NBIS · 6-K · 2026-10-22
UBSI: 8-K · earnings release
UBSI · 8-K · 2026-10-22
WETO: 6-K · other
WETO · 6-K · 2026-10-22
FSV: 6-K · earnings release
FSV · 6-K · 2026-10-22
NOK: 6-K · earnings release
NOK · 6-K · 2026-10-22
BNTX: 6-K · clinical trial
BNTX · 6-K · 2026-10-22
UNP: 8-K · earnings release
UNP · 8-K · 2026-10-22
SNN: 6-K · dividend
SNN · 6-K · 2026-10-22
HTOO: 6-K · material agreement
HTOO · 6-K · 2026-10-22
RELX: 6-K · earnings release
RELX · 6-K · 2026-10-22
BHP: 6-K · proxy statement
BHP · 6-K · 2026-10-22
LPL: 6-K · earnings release
LPL · 6-K · 2026-10-22
LYG: 6-K · leadership change
LYG · 6-K · 2026-10-22
BHP: 6-K · other
BHP · 6-K · 2026-10-22
COCO: 8-K · earnings release
COCO · 8-K · 2026-10-22
TCX: 8-K · material agreement
TCX · 8-K · 2026-10-22
CNOB: 8-K · earnings release
CNOB · 8-K · 2026-10-22
STBA: 8-K · earnings release
STBA · 8-K · 2026-10-22
LSCC: 8-K · leadership change
LSCC · 8-K · 2026-10-22
PHM: 8-K · earnings release
PHM · 8-K · 2026-10-22
NDAQ: 8-K · earnings release
NDAQ · 8-K · 2026-10-22
TSCO: 8-K · earnings release
TSCO · 8-K · 2026-10-22
LYG: 6-K · leadership change
LYG · 6-K · 2026-10-22
EDBL: 8-K · material agreement
EDBL · 8-K · 2026-10-22
CIVB: 8-K · earnings release
CIVB · 8-K · 2026-10-22
MSM: 8-K · earnings release
MSM · 8-K · 2026-10-22
VLY: 8-K · earnings release
VLY · 8-K · 2026-10-22
VC: 10-Q · periodic report
VC · 10-Q · 2026-10-22
AZN: 6-K · fda approval
AZN · 6-K · 2026-10-22
UZX: 6-K · delisting
UZX · 6-K · 2026-10-22
PHAR: 6-K · earnings release
PHAR · 6-K · 2026-10-22
CMCSA: 8-K · earnings release
CMCSA · 8-K · 2026-10-22
GCUMF: 6-K · ticker change
GCUMF · 6-K · 2026-10-22
VC: 8-K · earnings release
VC · 8-K · 2026-10-22
CBRE: 8-K · earnings release
CBRE · 8-K · 2026-10-22
DOV: 10-Q · periodic report
DOV · 10-Q · 2026-10-22
PG: 8-K · earnings release
PG · 8-K · 2026-10-22
ROP: 8-K · earnings release
ROP · 8-K · 2026-10-22
AAL: 10-Q · periodic report
AAL · 10-Q · 2026-10-22
RTO: 6-K · leadership change
RTO · 6-K · 2026-10-22
GUTS: 8-K · other
GUTS · 8-K · 2026-10-22
DOV: 8-K · earnings release
DOV · 8-K · 2026-10-22
BPOP: 8-K · earnings release
BPOP · 8-K · 2026-10-22
CRML: 6-K · acquisition merger
CRML · 6-K · 2026-10-22
AAL: 8-K · earnings release
AAL · 8-K · 2026-10-22
RELX: 6-K · share repurchase
RELX · 6-K · 2026-10-22
DOW: 8-K · earnings release
DOW · 8-K · 2026-10-22
CRNT: 6-K · other
CRNT · 6-K · 2026-10-22
LHX: 8-K · leadership change
LHX · 8-K · 2026-10-22
R: 8-K · earnings release
R · 8-K · 2026-10-22
BX: 8-K · earnings release
BX · 8-K · 2026-10-22
GRNQ: 8-K · leadership change
GRNQ · 8-K · 2026-10-22
RTO: 6-K · earnings release
RTO · 6-K · 2026-10-22
DAR: 8-K · earnings release
DAR · 8-K · 2026-10-22
GRAN: 6-K · proxy statement
GRAN · 6-K · 2026-10-22
DGX: 8-K · earnings release
DGX · 8-K · 2026-10-22
‹ Prev
1
3
4
5
6
7
8
9
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
73
Next ›
